Hydrogen breath test
|This article needs additional citations for verification. (December 2012)|
A hydrogen breath test (or HBT) is used as a diagnostic tool for people with irritable bowel syndrome, and common food intolerances. The test is simple, non-invasive, and is performed after a short period of fasting (typically 8–12 hours). Even though the test is normally known as a "Hydrogen Breath Test" some physicians may also test for methane in addition to hydrogen. Many studies have shown that some patients (approximately 35% or more) do not produce hydrogen but actually produce methane. Some patients produce a combination of the two gases. Other patients, who are known as "Non-Responders", don't produce any gas; it has not been yet determined whether they may actually produce another gas. In addition to hydrogen and methane, some facilities also utilize carbon dioxide (CO2) in the patients' breath to determine if the breath samples that are being analyzed are not contaminated (either with room air or bronchial dead space air).
Testing may be administered at hospitals, clinics, physician offices or if the physician/laboratory has the proper equipment and breath collection kit, patients can collect samples at home to then be mailed in for analysis.
Tests vary from country to country, so the following information is provided as a rough guide to typical uses of the hydrogen breath test:
Fructose malabsorption – the patient takes a base reading of hydrogen levels in his/her breath. The patient is then given a small amount of fructose, and then required to take readings every 15, 30 or 60 minutes for two to three hours. The basis of the test is a failure to absorb the given sugar, which is then metabolized by bacteria that give off either hydrogen or methane. Therefore, the more gas that is produced, the less absorption has occurred. If the level of hydrogen rises above 20 ppm (parts per million) over the lowest preceding value within the test period, the patient is typically diagnosed as a fructose malabsorber. If the patient produces methane then the parts per million for the methane typically rises 12 ppm over the lowest preceding value to be considered positive. If the patient produces both hydrogen and methane then the values are typically added together and the mean of the numbers is used to determine positive results, usually 15 ppm over the lowest preceding value.
Lactose malabsorption – the patient takes a base reading of hydrogen levels in his/her breath. The patient is then given a small amount of pure lactose (typically 20 to 25 g), and then required to take readings every 15, 30 or 60 minutes for two to three hours. If the level of hydrogen rises above 20 ppm (parts per million) over the lowest preceding value within the test period, the patient is typically diagnosed as a lactose malabsorber. If the patient produces methane then the parts per million for the methane typically rises 12 ppm over the lowest preceding value to be considered positive. If the patient produces both hydrogen and methane then the values are typically added together and the mean of the numbers is used to determine positive results, usually 15 ppm over the lowest preceding value. However, recent study suggest that testing may not correlate with any actual diagnosis.
Small Bowel Bacterial Overgrowth Syndrome (SBBOS) or Small Intestinal Bacterial Overgrowth (SIBO) – the patient is either given a challenge dose of glucose, also known as dextrose (75-100 grams), or lactulose (10 grams). A baseline breath sample is collected, and then additional samples are collected at 15 minute or 20 minute intervals for 3–5 hours. Positive diagnosis for a lactulose SIBO breath test – typically positive if the patient produces approximately 20 ppm of hydrogen and/or methane within the first two hours (indicates bacteria in the small intestine), followed by a much larger peak (colonic response). This is also known as a biphasic pattern. Lactulose is not absorbed by the digestive system and can help determine distal end bacterial overgrowth, which means the bacteria are lower in the small intestine.
||This section possibly contains original research. (April 2014)|
The idea that a SIBO should be several hours long and that distal overgrowth is important is wrong and is not supported by the scientific literature. The optimal testing is 1 hour. Small intestinal bacterial overgrowth (SIBO) occurs as a result of excessive numbers of bacteria inhabiting the proximal small intestine. Bacterial concentrations greater than 105 organisms per milliliter is diagnostic for SIBO. We know bacteria are colonizing the proximal and not the distal small intestine for several reasons. First, the gold standard method for detection of SIBO is jejunal aspirates. Intestinal fluid of the proximal intestine is sampled, not distal intestinal fluid. Secondly, the consequences of SIBO are the result of competition between bacteria and the human host for ingested nutrients in the intestine. Various functional consequences of bacterial infiltration cause enterocyte damage in the jejunum such as diminished disaccharidase activity, fat malabsorption, decreased amino acid transport and decreased vitamin B12 absorption. Thus, detection of proximal bacterial overgrowth is critical.
The SIBO breath test typically uses a 10 gram oral dose of lactulose for detection of proximal bacterial overgrowth. The best practice is to have breath samples collected at 20, 40, and 60 minutes after dosing. Since SIBO occurs in the proximal intestine, breath samples should be collected only within 1 hour after lactulose ingestion. This truly reflects proximal intestinal bacterial activity, not distal or colonic activity. The same argument is true if glucose is the substrate.
Lactulose is a carbohydrate that is not absorbed by humans. Lactulose is well known to measure oro-cecal transit time. The mean oro-cecal transit time in normal healthy individuals is 70 to 90 minutes. By 90 minutes, at least 50% of individuals would have delivered the lactulose dose to the colon. Approximately 90 to 95% of individuals have colonic bacteria that can metabolize lactulose to hydrogen or methane gas. Thus, any SIBO breath test that collects longer than 60 minutes may be measuring colonic activity. Diagnostic criteria of 20 ppm hydrogen and/or methane changes within 90 or 120 minutes will have higher positive rates of SIBO but this will reflect colonic activity not jejunal metabolism. A one hour SIBO breath test avoids false positive results by collecting breath up to 60 minutes.
Positive diagnosis for a glucose SIBO breath test - glucose is absorbed by the digestive system so studies have shown it to be harder to diagnose distal end bacterial overgrowth since the glucose typically doesn't reach the colon before being absorbed. An increase of approximately 12 ppm or more in hydrogen and/or methane during the breath test could conclude bacterial overgrowth. Recent study indicates "The role of testing for SIBO in individuals with suspected IBS remains unclear."
- Bratten JR, Spanier J, Jones MP (April 2008). "Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls.". The American Journal of Gastroenterology 103 (4): 958–63. doi:10.1111/j.1572-0241.2008.01785.x. PMID 18371134.
- Basilisco, G.; Risicato, R.; Bonazzi, P; Di Sario, A.; Portincasa, P. (2009). "H2-breath testing for evaluation of oro-caecal transit time". Aliment. Pharmacol. Ther. 29: 23–26.
- Eisenmann, A.; Amann, A.; Said, M.; Datta, B.; Ledochowski, M. (2008). "Implementation and interpretation of hydrogen breath tests". J. Breath Res. 2: 1–9.
- Simren, M.; Statzer, P-O. (2006). "Use and abuse of hydrogen breath tests". Gut 55: 297–303.
- Hirakawa, M.; Lida, M.; Kohrogi, N. et al. (1988). "Hydrogen breath test assessment of orocecal transit time: Comparison with barium meal study". Am. J. Gastroenterol. 83: 1361–1363.
- Bond, J.H.; Levitt, M.D.; Prentiss, R. (1975). "Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements". J. Lab. Clin. Med. 85: 546–555.
- Ghoshal, U. C. (2011). "How to interpret hydrogen breath tests". J. Neurogastroenterol. Motil. 17: 312–317.
- Ford, A. C.; Spiegel, B. M.; Talley, N. J.; Moayyedi, P. (August 12, 2009). "Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis". Clin. Gastroenterol. Hepatol. 7 (12): 1279–86. doi:10.1016/j.cgh.2009.06.031. PMID 19602448.